The discussion delves into the complexities of how genetic factors influence the immune response to EBV infection, highlighting the emergence of chronic active EBV as a significant health concern. Micah explains that while most people can control EBV, certain genetic mutations can lead to severe consequences, including recurrent mono-like symptoms and an increased risk of cancers, particularly EBV-associated gastric cancer, which is alarmingly prevalent worldwide.
